Back to Annual Meeting Page		American Public Health Association 133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA

Abstract #121950

Stanley H. Weiss, MD¹, Margaret L. Knight, RN, MEd², Daniel M. Rosenblum, PhD³, Jung Yee Kim, MPH³, Judith B. Klotz, DrPH⁴, David L. Hom, MS⁵, Loretta Morales, MPH⁵, Sharon L. Smith, MPH², Susan L. Collini, MPH³, Marcia M. Sass, ScD⁵, and Arnold M. Baskies, MD⁶. (1) Epidemiology, UMDNJ-New Jersey Medical School, 30 Bergen St, Bldg 16, Suite ADMC 1614, Newark, NJ 07107-3000, 973-972-7716, weiss@umdnj.edu, (2) Division of Epidemiology, Environmental & Occupational Health, Office of Cancer Control and Prevention, New Jersey Department of Health and Senior Services, P.O. Box 369, 3635 Quakerbridge Road, Trenton, NJ 08625-0369, (3) Preventive Medicine & Community Health, UMDNJ-New Jersey Medical School, 30 Bergen Street, ADMC 16, Suite 1614, Newark, NJ 07107-3000, (4) UMDNJ-School of Public Health, 30 Bergen Street, ADMC 16, Suite 1614, Newark, NJ 07107-3000, (5) New Jersey Medical School/UMDNJ Clinical Research Group, University of Medicine & Dentistry of New Jersey, 30 Bergen Street, Newark, NJ 07107-3000, (6) Rancocas Valley Surgical Associates, PA, 1235 Sequoia Road, Cherry Hill, NJ 08003

Enhancing the infrastructure for cancer control is a critical component of implementation of any state cancer control plan. In New Jersey, since a capacity and needs assessment (C/NA) had not yet been performed, a comprehensive data-driven C/NA became one of the first implementation steps of the New Jersey Comprehensive Cancer Control Plan (NJ CCCP). Following a review of best practices and based upon the diversity of communities within the state, a county-based strategy directly involving local experts was determined to be the best course for NJ. The C/NA was conducted by NJ CCCP County Evaluators, recruited based on knowledge of and interest in their communities. These County Evaluators formalized the local implementation arm of the NJ CCCP. The level of experience with scientific and epidemiologic data varied among the County Evaluators. Thus, centralized training and monitoring was essential; the types of scientific and programmatic guidance provided throughout the project will be summarized (see www.umdnj.edu/evalcweb/). In addition to enhancing personnel, new or augmented data systems may be needed to support implementation and monitoring of progress. The development of new data systems to fill data and data collection gaps should be built into the timeline for program planning. Ways to assess the adequacy of current data systems and two databases developed to support the NJ CCCP (the Cancer Resource Database of New Jersey and an electronic enhancement of the NJ CCCP) will be described. These resources are strengthening the infrastructure and increasing the effectiveness of cancer control efforts in NJ (see www.state.nj.us/health/ccp/).

Learning Objectives: Learning Objectives

At the conclusion of the session, the participant will be able to (
• Identify key components of a state comprehensive cancer control plan. (
• Assess the feasibility of and resources needed for conducting a comprehensive cancer capacity and needs assessment from an epidemiologic standpoint. (
• Describe strategies to expand partnerships with state and local cancer control planners. (
• Describe benefits and limitations of local implementation approaches. (
• Be able to apply a simplified methodology to develop prevalence estimates. (
• Better understand issues related to cancer disparities in Latino communities.

Presenting author's disclosure statement:

I wish to disclose that I have NO financial interests or other relationship with the manufactures of commercial products, suppliers of commercial services or commercial supporters.

Handout (.ppt format,

Recorded presentation